US Stock MarketDetailed Quotes

CRL Charles River

Watchlist
  • 183.420
  • -2.740-1.47%
Close Dec 30 16:00 ET
  • 183.140
  • -0.280-0.15%
Post 18:18 ET
9.38BMarket Cap22.90P/E (TTM)

About Charles River Company

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Company Profile

SymbolCRL
Company NameCharles River
Listing DateJun 23, 2000
Issue Price16.00
Founded1947
CEOMr. James C. Foster
MarketNYSE
Employees21800
Fiscal Year Ends12-28
Address251 Ballardvale Street
CityWilmington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01887
Phone1-781-222-6000
Websitehttp://www.criver.com

Company Executives

  • Name
  • Position
  • Salary
  • James C. Foster
  • Chairman of the Board, President and Chief Executive Officer
  • 14.10M
  • William D. Barbo
  • Corporate Executive Vice President and Chief Commercial Officer
  • 2.91M
  • Birgit Girshick
  • Chief Operating Officer
  • 4.99M
  • Michael Gunnar Knell
  • Corporate Senior Vice President and Chief Accounting Officer
  • --
  • Flavia H. Pease
  • Corporate Executive Vice President and Chief Financial Officer
  • 3.81M
  • Joseph W. LaPlume
  • Corporate Executive Vice President, Corporate Development and Strategy
  • 3.06M
  • Victoria L. Creamer
  • Corporate Executive Vice President
  • --
  • Shannon M. Parisotto
  • Corporate Executive Vice President
  • --
  • Reshema Kemps-Polanco
  • Director
  • --
  • Richard F. Wallman
  • Independent Director
  • 339.77K
  • Dr. Nancy C. Andrews, M.D.,PhD
  • Independent Director
  • 339.77K
  • Dr. Craig B. Thompson,M.D.
  • Independent Director
  • 437.78K
  • Dr. Martin W. Mackay, PhD
  • Independent Director
  • 336.02K
  • Robert J. Bertolini
  • Independent Director
  • 346.02K
  • Virginia M. Wilson
  • Independent Director
  • 346.02K
  • George Llado, Sr
  • Independent Director
  • 324.77K
  • George E. Massaro
  • Lead Independent Director
  • 371.02K
  • Dr. Deborah T. Kochevar
  • Independent Director
  • 339.77K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme CRO
CRO
Intraday-0.93%